Centocor Inc.
Merrill Lynch analyst Stuart Weisbrod raised his intermediate-term rating on Centocor Inc. to "above average" from "neutral" based on the positive implications of the company's plan to repurchase Tocor II, new data on CentoRx and the recent agreement with Tanabe for CenTNF. As a result, Weisbrod said, he is increasingly